查詢結果分析
相關文獻
- Validity of Two Instruments Measuring Nausea and Vomiting by Children Who Received Cancer Chemotherapy
- 主要照顧者面對初次化學治療返家之癌症病童居家照護的經驗
- 坐到站之二維與三維動作分析比較:初步研究
- Successful Treatment of a Bulky Seminoma in an Abdominal Undescended Testis: A Case Report
- Ifosfamide-Based Chemotherapy for Previously Treated Lung Cancer Patients
- 中國人的家族主義:概念分析與實徵衡鑑
- 測量工具之翻譯與效度
- Treatment of Ultra-High Risk Gestational Trophoblastic Disease by an EMA/CE Regimen
- The Experience of Combination of Chemotherapy and Surgery in Treatment of Advanced Nonseminomatous Germ Cell Tumor of the Testis
- 農業郵寄調查中未回覆問題之探討
頁籤選單縮合
題 名 | Validity of Two Instruments Measuring Nausea and Vomiting by Children Who Received Cancer Chemotherapy=兩種由癌症兒童測量之噁心與嘔吐量表之效度 |
---|---|
作 者 | 駱麗華; | 書刊名 | 成功大學學報 |
卷 期 | 33(科技.醫學篇) 民87.11 |
頁 次 | 頁167-185 |
分類號 | 419.77 |
關鍵詞 | 急性及遲發性噁心與嘔吐; 化學治療; 兒童癌症; 效度; Acute and delayed nausea and vomiting; Chemotherapy; Children with cancer; Validity; |
語 文 | 英文(English) |
中文摘要 | 癌症兒童接受化學治療常會有噁心與嘔吐現象,在確認癌症兒童之急性或遲發性 之噁心與嘔吐型式前,宜先建立測量工具之效度。本研究目的在建立兩種(ARINVc 和NV-VAS)由癌症兒童測量之噁心與嘔吐量表之效標效度與同時效度,方法為以 美國國家癌症研究院之噁心與嘔吐評估標準為效標(NCI-NV),26位8∼18歲癌症 兒童接受各種化學治療方案為樣本,化學治療開始後每 12小時共三天,由兒童 評估其本身之噁心與嘔吐,記錄於上述兩種量表中,即(1)修正之羅氏噁心與嘔 吐量表(ARINVc)和(2)噁心與嘔吐視覺類比量表(NV-VAS)。所得結果以皮爾森相 關係數,分析此二種噁心與嘔吐量表於化學治療後三天內之得分。結果發現ARINVc 與NCI-NV得分具統計學上有意義之高相關(t=.73-.85,p<.01);NV-VAS與NCI-NV 間之相關係數雖稍低,但仍達統計學上之意義(r=.52-.65, p<.01);同時ARINVc 與NV-VAS兩個被測試的量表之間,其噁心與嘔吐總分亦達統計學上有意義之高相 關(r=.60- .78, p<.01)。因此,修正之羅氏噁心與嘔吐量表(ARINVc)及噁心與 嘔吐視覺類比量表(NV-VAS)已具效標效度與同時效度,可用於8-18歲之癌症兒童 接受化學治療,以測量其急性及遲發性之噁心與嘔吐型式。 |
英文摘要 | Children who received cancer chemotherapy frequently experienced nausea and vomiting (NV). Validity of the instruments of NV needs to be established before identifying the patterns Of acute (Day 1) and delayed (Day 2-3) NV in children with cancer. Objectives: To establish the criterion-related validity and concurrent validity of two rating instruments ofNV (ARINVc and NV-VAS) by children who received cancer chemotherapy from Day 1 to Day 3. Methods: Participants included 26 children aged 8-18 years old who received a variety of emetogenicity of cancer chemotherapy protocols. Following the criteria for NV from the National Cancer Institute (NCI-NV), the research nurse measured children's NV daily. Both ARINVc (Adapted Rhodes Index Nausea and Vomiting for Children) and NV-VAS (Visual Analogue Scale of Nausea and Vomiting) were measured by children every 12 hours for three days after the administration of cancer chemotherapy. Data were analyzed by using Pearson's correlation between the above two instruments on total scores or subscores of NV from Day 1 to Day 3. Results: Criterion-related validity of total scores of acute and delayed NV were established between ARINVc and NCI-NV (r=.73-.85, p<.01), and between NV-VAS and NCI-NV (r=.52- .65, p<.01). Significantly positive associations between ARINVc and NV-VAS were found from Day 1 to Day 3 on total scores (r=.60- .78, p<.01), nausea sub-scores (r =.49- .76, p<.05), and vomiting subscores (r =.60- .76, p< .05). Conclusions: Both ARINVc and NV-VAS are valid to measure acute and delayed nausea and vomiting by children with cancer, and they also are easy to use in 8-18 year-old children who received cancer chemotherapy. |
本系統中英文摘要資訊取自各篇刊載內容。